A5103282851- Tuberculosis Research and Epidemiology
- Healthcare Systems and Reforms
- Health Systems, Economic Evaluations, Quality of Life
- Infectious Diseases and Tuberculosis
- Pneumonia and Respiratory Infections
- Diagnosis and treatment of tuberculosis
- COVID-19 epidemiological studies
- COVID-19 Pandemic Impacts
- Pharmaceutical Economics and Policy
- Employment and Welfare Studies
Karolinska Institutet
2019-2024
Up to fifty percent of microbiologically cured tuberculosis (TB) patients may be left with permanent, moderate or severe pulmonary function impairment. Very few studies have systematically examined outcomes in understand the pathophysiologic basis and long-term socio-economic consequences this injury. The planned multi-country, multi-centre observational TB cohort study, aims advance understanding clinical, microbiological, immunological risk factors affecting outcome TB. It will also...
The WHO developed a generic ‘TB patient cost survey’ tool and standardized approach to assess the direct indirect costs of TB incurred by patients their households, estimate proportion experiencing catastrophic costs, measure impact interventions reduce costs. While is facility-based cross-sectional survey, this needs be adapted for longitudinal studies. A may overcome some limitations design economic burden more precisely. We describe process creating instrument its application Sequel...
OBJECTIVE: To determine the costs and catastrophic incurred by drug-susceptible (DS) pulmonary TB patients in The Gambia. METHODS: This observational study collected cost socio-economic data using a micro-costing approach from household perspective 244 adult DS-TB with receiving treatment through national programme We used between 2017 2020 an adapted version of WHO generic patient survey instrument to estimate proportion experiencing (≥20% income). RESULTS: mean total episode was $104.11...